cbdMD financials
$0.4690+1.19%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Jun 30 | Q2 '26 Mar 31 | Q1 '26 Dec 31 | Q4 '25 Sep 30 | Q3 '25 Jun 30 | Q2 '25 Mar 31 | Q1 '25 Dec 31 | Q4 '24 Sep 30 | Q3 '24 Jun 30 | Q2 '24 Mar 31 | Q1 '24 Dec 31 | Q4 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $5.6M | $5.0M | $4.7M | $4.6M | $4.7M | $5.1M | $4.6M | $5.2M | $4.4M | $5.4M | $5.7M |
| Gross profit | $3.0M | $3.3M | $3.0M | $2.8M | $2.8M | $3.0M | $3.4M | $2.5M | $3.4M | $2.6M | $3.6M | $3.5M |
| Gross margin | 54.7% | 57.7% | 59.8% | 58.8% | 61.5% | 62.3% | 66.5% | 53.9% | 65.8% | 59.0% | 66.2% | 62.1% |
| Operating income | -$1.1M | -$800.8K | -$286.3K | -$685.8K | -$904.7K | -$485.8K | -$86.3K | -$316.6K | -$382.0K | -$1.5M | -$996.1K | -$15.0M |
| Net income | -$1.2M | -$876.8K | -$324.6K | -$680.0K | -$1.2M | -$1.5M | -$985.4K | -$1.2M | -$540.8K | -$4.0M | -$2.0M | -$16.9M |
| Net margin | −21.6% | −15.5% | −6.5% | −14.4% | −26.7% | −31.2% | −19.3% | −25.4% | −10.5% | −91.6% | −37.2% | −295.5% |
| Diluted EPS | $-0.11 | $-0.08 | $-0.04 | $-0.08 | $-0.21 | $-1.90 | $-1.73 | $-0.90 | $-0.15 | $-10.84 | $-0.67 | $-44.66 |
| EBITDA | -$871.5K | -$549.2K | -$40.8K | -$423.8K | -$624.5K | -$199.9K | $211.7K | -$28.8K | -$94.3K | -$1.3M | -$782.1K | -$1.3M |
| Operating cash flow | -$442.2K | -$722.5K | -$812.5K | -$240.7K | -$704.2K | -$189.5K | -$317.9K | $167.4K | $289.8K | -$704.1K | -$105.9K | -$263.5K |
| Free cash flow | -$460.2K | -$728.2K | -$977.3K | -$243.6K | -$705.7K | -$205.0K | -$482.3K | $157.4K | $289.8K | -$708.7K | -$290.5K | -$383.7K |
| Diluted shares | 10.6M | 10.4M | 9.0M | 9.0M | 5.8M | 0.8M | 0.6M | 1.3M | 3.6M | 0.4M | 3.0M | 0.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.1M | $2.6M | $3.4M | $2.3M | $1.1M | $1.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $7.3K | $7.3K | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $13.1M | $12.3M | $11.8M | $10.4M | $9.9M | $10.9M |
| Total liabilities | $4.9M | $3.0M | $2.8M | $3.2M | $3.8M | $10.3M |
| Shareholders' equity | $8.2M | $9.3M | $9.0M | $7.2M | $6.1M | $665.8K |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology